Ads
related to: contrave vs qsymia chart
Search results
Results From The WOW.Com Content Network
Naltrexone/bupropion, sold under the brand name Contrave among others, is a fixed-dose combination medication for the management of chronic obesity in adults in combination with a reduced-calorie diet and increased physical activity. [4] [6] It contains naltrexone, an opioid antagonist, and bupropion, an aminoketone atypical antidepressant. [4]
Contrave. Contrave is yet another oral weight loss medication. ... Like many Ozempic alternatives, Qsymia is FDA-approved for weight management in people with a BMI of 30 or more, or 27 or more ...
Phentermine-topiramate. Sold under the brand name Qsymia, it is a combination of the drugs phentermine and topiramate, which are taken orally. The medications are used, along with changes in diet ...
Only 13% of patients who started taking Contrave from Orexigen Therapeutics and 10% of those who started on Qsymia from Vivus between 2015 and 2022 were still filling their prescriptions a year ...
Orlistat (Xenical), the most commonly used medication to treat obesity and sibutramine (Meridia), a medication that was withdrawn due to cardiovascular side effects. Anti-obesity medication or weight loss medications are pharmacological agents that reduce or control excess body fat.
[8] [14] Naltrexone, as naltrexone/bupropion (brand name Contrave), is also used to treat obesity. [15] It is on the World Health Organization's List of Essential Medicines. [16] In 2021, it was the 254th most commonly prescribed medication in the United States, with more than 1 million prescriptions. [17] [18]
Contrave (naltrexone-bupropion) Topamax (topiramate) Qsymia (phentermine-topiramate) Xenical (orlistat) If you’re looking into weight loss treatments, drugs aren’t your only option, either.
Phentermine and topiramate was developed by Vivus, a California pharmaceutical company. In December 2009, Vivus, Inc. submitted a new drug application (NDA) to the FDA and on 1 March 2010, Vivus, Inc. announced that the FDA accepted the NDA for review.
Ad
related to: contrave vs qsymia chart